Skip to main content

WPI 2227 Pill - brown & white capsule/oblong

Pill with imprint WPI 2227 is Brown & White, Capsule/Oblong and has been identified as Flutamide 125 mg. It is supplied by Watson Pharmaceuticals, Inc.

Flutamide is used in the treatment of Prostate Cancer; Hirsutism and belongs to the drug classes antiandrogens, hormones/antineoplastics. There is positive evidence of human fetal risk during pregnancy. Flutamide 125 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WPI 2227

Flutamide 125 mg WPI 2227
Flutamide 125 mg WPI 2227
Flutamide 125 mg WPI 2227
Flutamide 125 mg WPI 2227
Flutamide 125 mg WPI 2227


WPI 2227
125 mg
Brown & White
Prescription only
Drug Class
Antiandrogens, Hormones/antineoplastics
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Watson Pharmaceuticals, Inc.
National Drug Code (NDC)
00591-2466 (Discontinued)
Inactive Ingredients
lactose monohydrate, magnesium stearate, povidone, corn starch, sodium lauryl sulfate, ferrosoferric oxide, gelatin, ferric oxide red, ferric oxide yellow, titanium dioxide, D&C Yellow No. 10, FD&C Blue No. 1, FD&C Blue No. 2, FD&C Red No. 40, butyl alcohol, propylene glycol

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.